R&D Trends 2012 - Pharmaceutical Companies use Externalization & Collaboration ... 
MarketWatch (press release)
Mounting pressure to reduce the cost of R&D and boost productivity has resulted in pharma companies undertaking radical strategies as the search for efficiency continues. With the ongoing patent cliff triggering a wave of patent expiries, ...

and more » 

Drugmakers Assess Contingency Plan For Greece 
Fox Business
By Sten Stovall LONDON ? Global drug companies are working with European authorities on how to keep medicines flowing into Greece if the country is forced out of the region's single currency and can't pay for such products. "There is no concrete plan ...

and more » 

FDA's $6.4 Billion Plan for Quick Reviews Moves to Senate 
Bloomberg
The figure includes $1.56 billion from generic- drug companies such as Canonsburg, Pennsylvania-based Mylan, which had been exempt from such review fees. Mylan, the largest US generic-drug company, led the fee effort for its industry to quicken review ...

and more » 

Pharmaceutical Industry Labor-Management Association (PILMA) Statement on ... 
MarketWatch (press release)
WASHINGTON, May 17, 2012 /PRNewswire via COMTEX/ -- The Pharmaceutical Industry Labor-Management Association (PILMA) today called on members of the Senate to support the swift and streamlined process for the reauthorization of the Prescription Drug ...

and more » 

Lobbying group for pharma companies says US risks losing research jobs to ... 
The Star-Ledger - NJ.com
By Bloomberg News Star-Ledger file photoOther countries are aggressively wooing researchers and the resources of major US pharmaceutical companies, according to the industry's leading trade group. The US risks losing thousands of research jobs as ...
US risks losing drug research jobs overseas, top lobbyist says Ct Post

all 9 news articles » 

Drug Plan Draws Fire in India 
Wall Street Journal
By RUMMAN AHMED BANGALORE, India?India's government is facing stiff resistance from foreign and domestic pharmaceutical companies over its plan to limit prices for drugs severely. Rafiq Maqbool/Associated Press In this file photo, a pharmacist is seen ...
Should drug prices be regulated? Daily News & Analysis

all 12 news articles » 

New Competitive Arena Emerges for Pharmaceutical Companies in Healthcare's ... 
MarketWatch (press release)
NEW YORK, May 17, 2012 /PRNewswire via COMTEX/ -- Pharmaceutical companies that are first to meet healthcare's new expectations of value could have an advantage in the competition for market share and brand differentiation, according to a report ...
Drug companies should meet payers' expectations of value, report finds Drug Store News
PwC Survey: Drug Manufacturers Must Demonstrate Clinical, Economic Benefits of ... LifeHealthPro

all 7 news articles » 

New competitive arena emerges for US Pharma in changing payment landscape ... 
The Pharma Letter
Pharmaceutical companies that are first to meet health care's new expectations of value could have an advantage in the competition for market share and brand differentiation, according to a report published today by the Health Research Institute (HRI) ...

 

GSK Medicine Bank: creating shared value in Thailand 
The Guardian (blog)
Pharma companies haven't exactly been the sweetheart of the development community, with high profits from expensive medicines generating serious questions around their social licence to operate. Yet some good examples of shared value are emerging, ...

 

Research and Markets: Comparisons of Pharmaceutical Manufacturing between ... 
SunHerald.com
The current global environment is forcing all pharmaceutical companies to improve their efficiency and reduce cost. As such, almost all of them have recently made drastic changes in their business strategies. They have been seeking the balances between ...

and more »